Czech-based CB21 Pharma said it has obtained approval for a CBD-infused suppository which will go on the market in pharmacies and online in February. The company said the product helps with healing after childbirth, gynecological procedures and chemotherapy. CB21 said it has plans to develop other products for dentistry and neurology in the coming years. Investments in the development, research and production of CB21 Pharma are financed by Czech billionaire Karel Janeček. The company received a certificate of good manufacturing practice for the production of CBD for pharmaceutical purposes last year.
Posted By: HempToday® January 12, 2021
Like HempToday? How you can support us
Your donations help us to keep HempToday open for all readers, regardless of what they can afford to pay. Through this “information equality” we're able to support hemp entrepreneurs and stakeholders all over the world by keeping a spotlight on hemp and all the promise it offers for economic development and healing our planet.